. 2010 Dec 29;20(9):1491–1501. doi: 10.1089/scd.2010.0373

Table 3.

Cardiac Function, Clinical Parameters, and Mobilization of BM-CPCs Immediately Pre- and Post- and at 3, 6, and 12 Months Postbone Marrow Cell Transplantation in the Intervention Group

	Immediately pre-BMC-Tx	Immediately post-BMC-Tx	3 months after BMC-Tx	6 months after BMC-Tx	12 months after BMC-Tx
Global EF (%)	46 ± 10		53 ± 8^a		52 ± 8^a
The size of infarct area (%)	27 ± 9		19 ± 8^b		18 ± 5^b
Infarct wall movement velocity (cm/s)	1.80 ± 0.74		2.98 ± 0.89^b		3.45 ± 0.5^b
LVEDV (mL)	138 ± 34		139 ± 32^c		138 ± 32^c
LVESV (mL)	75 ± 20		65 ± 10^a		66 ± 10^a
SVI (mL/m)	34 ± 10		42 ± 9^a		41 ± 8^a
CD34/45+ BM-CPCs	190 ± 50	193 ± 50^c	290 ± 110^a	288 ± 100^a	315 ± 90^b
CD133/45+ BM-CPCs	51 ± 20	52 ± 20^c	90 ± 25^a	99 ± 20^b	95 ± 25^a
BNP (pg/mL)	178 ± 89		65 ± 28^b	61 ± 19^b	60 ± 15^b
NYHA classification	2.40 ± 0.8		1.80 ± 0.8^b	1.7 ± 0.8^b	1.5 ± 0.8^b

^{^a}

P = 0.01–0.001 (compared with baseline).

^{^b}

P < 0.001 (compared with baseline).

^{^c}

P = not significant.